Neuronetics, inc. (STIM)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Revenues

11,476

17,356

16,000

16,572

12,728

-

-

-

-

-

-

-

-

Cost of revenues

2,811

4,219

4,192

4,171

2,807

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

12,108

10,491

10,308

7,526

Cost of revenues

-

-

-

-

-

-

-

-

-

2,957

2,636

2,501

1,538

Gross Profit

8,665

13,137

11,808

12,401

9,921

11,924

10,703

10,007

7,695

9,151

7,855

7,807

5,988

Operating expenses:
Sales and marketing

10,723

11,516

10,362

11,523

9,592

10,648

9,672

9,835

8,109

8,628

6,566

6,400

6,306

General and administrative

5,287

4,312

4,285

4,261

4,599

4,715

3,238

3,078

2,636

2,837

2,256

1,837

1,642

Research and development

3,021

4,248

3,489

3,224

2,786

2,222

2,125

2,330

1,555

1,919

1,843

2,147

2,028

Total operating expenses

19,031

20,076

18,136

19,008

16,977

17,585

15,035

15,243

12,300

13,384

10,665

10,384

9,976

Loss from Operations

-10,366

-6,939

-6,328

-6,607

-7,056

-5,661

-4,332

-5,236

-4,605

-4,233

-2,810

-2,577

-3,988

Other (income) expense:
Interest expense

1,523

905

930

931

919

939

928

900

921

740

807

711

550

Other (income) expense, net

200

290

391

444

446

457

299

-1,360

29

49

-136

420

24

Loss on extinguishment of debt

-924

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-12,613

-7,554

-6,867

-7,094

-7,529

-6,143

-4,961

-7,496

-5,497

-4,924

-3,753

-2,868

-4,514

Net loss per share of common stock outstanding, basic and diluted

-0.68

-0.41

-0.37

-0.39

-0.42

-0.35

-0.29

-30.60

-24.43

-23.34

-19.35

-16.58

-27.03

Weighted-average common shares outstanding, basic and diluted

18,681

18,627

18,508

18,351

18,026

17,655

17,382

245

226

211

194

173

167